These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 33858954)

  • 1. Evaluating meaningful levels of financial toxicity in gynecologic cancers.
    Esselen KM; Gompers A; Hacker MR; Bouberhan S; Shea M; Summerlin SS; Rucker LR; Huh WK; Pisu M; Liang MI
    Int J Gynecol Cancer; 2021 Jun; 31(6):801-806. PubMed ID: 33858954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crowdsourcing to measure financial toxicity in gynecologic oncology.
    Esselen KM; Stack-Dunnbier H; Gompers A; Hacker MR
    Gynecol Oncol; 2021 May; 161(2):595-600. PubMed ID: 33551197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Financial toxicity in gynecologic oncology.
    Bouberhan S; Shea M; Kennedy A; Erlinger A; Stack-Dunnbier H; Buss MK; Moss L; Nolan K; Awtrey C; Dalrymple JL; Garrett L; Liu FW; Hacker MR; Esselen KM
    Gynecol Oncol; 2019 Jul; 154(1):8-12. PubMed ID: 31053404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors associated with increased financial toxicity after the completion of radiation treatment for gynecologic cancer.
    Esselen KM; Baig RA; Gompers A; Stack-Dunnbier H; Hacker MR; Jang JW
    Support Care Cancer; 2023 Jun; 31(7):388. PubMed ID: 37300721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Financial toxicity in gynecologic oncology: a multi-practice survey.
    Smith AJ; Sharma MH; Powell K; Doherty M; Hinkle SN; Ko EM
    Int J Gynecol Cancer; 2024 Jun; 34(6):919-925. PubMed ID: 38346844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extensive financial hardship among gynecologic cancer patients starting a new line of therapy.
    Liang MI; Pisu M; Summerlin SS; Boitano TKL; Blanchard CT; Bhatia S; Huh WK
    Gynecol Oncol; 2020 Feb; 156(2):271-277. PubMed ID: 31771866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beyond Medical Bills: High Prevalence of Financial Toxicity and Diverse Management Strategies Among Vietnamese Patients With Cancer.
    Tran BT; Nguyen TG; Le DD; Nguyen MT; Nguyen NPT; Nguyen MH; Ong TD
    J Prev Med Public Health; 2024 Jul; 57(4):407-419. PubMed ID: 38938045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient-reported benefit from proposed interventions to reduce financial toxicity during cancer treatment.
    Aviki EM; Thom B; Braxton K; Chi AJ; Manning-Geist B; Chino F; Brown CL; Abu-Rustum NR; Gany FM
    Support Care Cancer; 2022 Mar; 30(3):2713-2721. PubMed ID: 34822002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of Financial Toxicity and Coping Strategies Associated With Cancer Treatment Among Caregivers of Patients With Cancer From a Lower-Middle-Income Country.
    Mathew M; Rao AP; Pai A; Sumit K; Lewis S
    JCO Glob Oncol; 2024 Jul; 10():e2300397. PubMed ID: 39052946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Financial toxicity: A practical review for gynecologic oncology teams to understand and address patient-level financial burdens.
    Liang MI; Harrison R; Aviki EM; Esselen KM; Nitecki R; Meyer L
    Gynecol Oncol; 2023 Mar; 170():317-327. PubMed ID: 36758422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Financial toxicity in patients with gynecologic malignancies: a cross sectional study.
    Zeybek B; Webster E; Pogosian N; Tymon-Rosario J; Balch A; Altwerger G; Clark M; Menderes G; Huang G; Azodi M; Ratner ES; Schwartz PE; Santin AD; Andikyan V
    J Gynecol Oncol; 2021 Nov; 32(6):e87. PubMed ID: 34431257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Racial differences in employment and cost-management behaviors in patients with metastatic breast cancer.
    Samuel CA; Spencer JC; Rosenstein DL; Reeder-Hayes KE; Manning ML; Sellers JB; Wheeler SB
    Breast Cancer Res Treat; 2020 Jan; 179(1):207-215. PubMed ID: 31555940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Financial toxicity assessment and associated factors analysis of patients with cancer in China.
    Qiu Z; Yao L; Jiang J
    Support Care Cancer; 2023 Apr; 31(5):264. PubMed ID: 37058171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Financial toxicity, coping strategies, and quality of life among Chinese patients with hematologic malignancies: a cross-sectional study.
    Wang Y; Luo B; Wang X; Ji Q; Cao X
    Support Care Cancer; 2024 Jul; 32(7):475. PubMed ID: 38954081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coping Mechanisms for Financial Toxicity Among Patients With Metastatic Prostate Cancer: A Survey-based Assessment.
    Joyce DD; Schulte PJ; Kwon ED; Dusetzina SB; Moses KA; Sharma V; Penson DF; Tilburt JC; Boorjian SA
    J Urol; 2023 Aug; 210(2):290-298. PubMed ID: 37416955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Financial toxicity, mental health, and gynecologic cancer treatment: The effect of the COVID-19 pandemic among low-income women in New York City.
    Chen YS; Zhou ZN; Glynn SM; Frey MK; Balogun OD; Kanis M; Holcomb K; Gorelick C; Thomas C; Christos PJ; Chapman-Davis E
    Cancer; 2021 Jul; 127(14):2399-2408. PubMed ID: 33899220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Greater financial toxicity relates to greater distress and worse quality of life among breast and gynecologic cancer survivors.
    Benedict C; Fisher S; Schapira L; Chao S; Sackeyfio S; Sullivan T; Pollom E; Berek JS; Kurian AW; Palesh O
    Psychooncology; 2022 Jan; 31(1):9-20. PubMed ID: 34224603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Financial burden and recommended multilevel solutions among caregivers of pediatric hematopoietic stem cell transplant recipients.
    Waters AR; Biddell CB; Killela M; Kasow KA; Page K; Wheeler SB; Drier SW; Kelly MS; Robles J; Spees LP
    Pediatr Blood Cancer; 2023 Dec; 70(12):e30700. PubMed ID: 37776093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for financial toxicity in patients with gynecologic cancer.
    Aviki EM; Manning-Geist BL; Sokolowski SS; Newman T; Blinder VS; Chino F; Doyle SM; Liebhaber A; Gordhandas SB; Brown CL; Broach V; Chi DS; Jewell EL; Leitao MM; Long Roche K; Mueller JJ; Sonoda Y; Zivanovic O; Gardner GJ; Abu-Rustum NR
    Am J Obstet Gynecol; 2022 Jun; 226(6):817.e1-817.e9. PubMed ID: 34902319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Financial Toxicity of Nephrolithiasis: The First Assessment of the Economic Stresses of Kidney Stone Treatment.
    Green BW; Labagnara K; Feiertag N; Gupta K; Donnelly J; Watts KL; Crivelli JJ; Assimos DG; Small AC
    Urology; 2022 Dec; 170():46-52. PubMed ID: 36183747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.